Ultra-low-field MR brain imaging.

The Hyperfine, Inc. Swoop system brings MR brain imaging within reach for clinicians to help them make timely clinical decisions in a variety of professional healthcare settings across a range of conditions.

The Swoop system is the only FDA-cleared portable MR brain imaging system that combines safe, ultra-low-field magnetic resonance with proprietary artificial intelligence.

The Swoop system potentially enables timelier treatment decisions, quicker discharges, and more efficient use of staff and hospital resources.

Learn More

The Swoop system supports efficient clinical decision-making and an improved patient experience.

Images acquired with the Swoop system enable clinicians to make timely clinical decisions without waiting for access to conventional MRI and without the costly and disruptive risks of patient transport. Best of all, patients can remain in a safe and comfortable setting, with family and caregivers by their side, and a lower chance of adverse events due to transport.

Learn More

The Swoop system provides portable brain imaging.

Move the imaging equipment, not the patient. The Swoop system does not require special siting or shielding and fits in elevators and through doorways to plug into a regular outlet for use in a variety of clinical settings. Clinicians are no longer limited to conventional MRI or CT scans in evaluating a wide range of neurological conditions.

Learn More

The Swoop system expands access to brain imaging and helps optimize resource utilization.

The Swoop system brings brain imaging to more healthcare settings and patients. Rather than sending every patient to the tightly scheduled and high-cost conventional MRI, hospitals can balance the load with the Swoop system. Timely and effective triage and treatment shorten stays and free up beds for the best use of hospital capacity and effective cost control.

Learn More

The Swoop system provides MR brain imaging across a wide range of use cases.

Clinicians can potentially use the Swoop system to evaluate conditions as diverse as stroke (>5mm) follow-up, ventriculomegaly, intracranial mass effect, and more. Clinicians can also potentially use the Swoop system to monitor a patient's response to therapies.

Learn More